Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
Department of Endocrinology and Metabolism, Beijing Pinggu Hospital, Beijing, China.
Clin Endocrinol (Oxf). 2024 Nov;101(5):466-474. doi: 10.1111/cen.15126. Epub 2024 Aug 27.
Gain-of-function (GOF) variants of KCNJ11 cause neonate diabetes and maturity-onset diabetes of the young (KCNJ11-MODY), while loss-of-function (LOF) variants lead to hyperinsulinemia hypoglycemia and subsequent diabetes. Given the limited research of KCNJ11-MODY, we aimed to analyse its phenotypic features and prevalence in Chinese patients with early-onset type 2 diabetes (EOD).
DESIGN, PATIENTS AND MEASUREMENTS: We performed next-generation sequencing on 679 Chinese EOD patients to screen for KCNJ11 exons variants. Bioinformatics prediction and the American College of Medical Genetics and Genomics guidelines was used to determine the pathogenicity and diagnosed KCNJ11-MODY. A literature review was conducted to investigate the phenotypic features of KCNJ11-MODY.
We identified six predicted deleterious rare variants in six EOD patients (0.88%). They were classified as uncertain significance (variant of uncertain significance [VUS]), but more common in this EOD cohort than a general Chinese population database, however, without significant difference (53/10,588, 0.50%) (p = .268). Among 80 previously reported patients with KCNJ11-MODY, 23.8% (19/80) carried 9 (32.1%) LOF variants, who had significantly older age at diagnosis, higher birthweight and higher fasting C-peptide compared to patients with GOF variants. Many patients carrying VUS were not correctly diagnosed.
Some rare variants of KCNJ11 might contribute to the development of Chinese EOD, although available evidence has not enough power to support them as cause of KCNJ11-MODY. The clinical features of LOF variants were different from GOF variants in KCNJ11-MODY patients. It is necessary to evaluate the pathogenicity of VUS through function experiments.
KCNJ11 的获得性功能(GOF)变异可导致新生儿糖尿病和青年发病的成年型糖尿病(KCNJ11-MODY),而失功能(LOF)变异则导致高胰岛素血症低血糖症和随后的糖尿病。鉴于 KCNJ11-MODY 的研究有限,我们旨在分析其表型特征和在中国早发性 2 型糖尿病(EOD)患者中的患病率。
设计、患者和测量方法:我们对 679 例中国 EOD 患者进行了下一代测序,以筛选 KCNJ11 外显子变异。生物信息学预测和美国医学遗传学与基因组学学院指南用于确定致病性并诊断 KCNJ11-MODY。进行文献回顾以研究 KCNJ11-MODY 的表型特征。
我们在 6 例 EOD 患者中发现了 6 个预测的有害罕见变异(0.88%)。它们被归类为意义不确定(意义不确定的变异[VUS]),但在该 EOD 队列中比一般中国人群数据库更常见,但无显著差异(53/10588,0.50%)(p=0.268)。在 80 例先前报道的 KCNJ11-MODY 患者中,23.8%(19/80)携带 9 个(32.1%)LOF 变异,与 GOF 变异患者相比,这些患者的诊断年龄更大,出生体重更高,空腹 C 肽更高。许多携带 VUS 的患者未被正确诊断。
KCNJ11 的一些罕见变异可能有助于中国 EOD 的发生,尽管现有证据还不足以支持它们为 KCNJ11-MODY 的病因。KCNJ11-MODY 患者中 LOF 变异的临床特征与 GOF 变异不同。有必要通过功能实验评估 VUS 的致病性。